Betapace
indicated to manage ventricular and supraventricular arrhythmias to mitigate the risk of life-threatening heart rhythm irregularities.
Strengths: 40mg
Where to Check Availability
Medicine details
- Alternative names
Sotacor
- Therapeutic class
Class III Antiarrhythmic
- Pharmacological class
Non-selective Beta-blocker
- Minor side effects
fatigue; dizziness; headache
- Moderate side effects
bradycardia; dyspnoea; nausea
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Bristol-Myers Squibb
- Onset Time
1–2 hours
- Duration
12–24 hours
- Storage instructions
Store at room temperature.
- Drug interactions
amiodarone; diuretics; calcium channel blockers
- Age restrictions
Use with caution in children.
- Pregnancy and breastfeeding
Pregnancy caution advised. Avoid during breastfeeding.
Contraindications
asthma; bradycardia; second or third degree heart block; uncompensated heart failure
Precautions and warnings
regular ecg monitoring required; electrolyte imbalance must be corrected before treatment
Serious side effects
torsade de pointes — requires immediate medical attention; heart block — requires immediate medical attention
Patient summary
indicated to manage ventricular and supraventricular arrhythmias to mitigate the risk of life-threatening heart rhythm irregularities.
Mechanism of action
Sotalol acts as a non-selective beta-adrenoreceptor antagonist and also exhibits Class III antiarrhythmic properties by prolonging the cardiac action potential, which helps stabilize heart rhythm.
Betapace
indicated to manage ventricular and supraventricular arrhythmias to mitigate the risk of life-threatening heart rhythm irregularities.
Editorial Notes
- Active ingredient(s): Sotalol
- Listed indication(s): Ventricular Arrhythmias, Atrial Fibrillation
Available option
- 120 tablets - 40 mg16-40-mg-2251